Search Results - "LIN, EDWARD F."

Recurrent melanoma 25 years after initial diagnosis, presenting as metastatic disease early after heart transplantation by Rubinstein, Gal, Izar, Benjamin, McDonnell, Diana E, Fernandez Valledor, Andrea, Fried, Justin A, Clerkin, Kevin, Lin, Edward F, Lotan, Dor, Latif, Farhana, Sayer, Gabriel, Uriel, Nir, Raikhelkar, Jayant K

“…Cancer survivors (CS) comprise a particularly high-risk group for both de-novo and recurrent malignancies after solid organ transplantation. We report a case…”
Get full text

Predictors of High Defibrillation Threshold in the Modern Era by LIN, EDWARD F., DALAL, DARSHAN, CHENG, ALAN, MARINE, JOSEPH E., NAZARIAN, SAMAN, SINHA, SUNIL, SPRAGG, DAVID D., TANDRI, HARIKRISHNA, HALPERIN, HENRY, CALKINS, HUGH, BERGER, RONALD D., TOMASELLI, GORDON F., HENRIKSON, CHARLES A.

“…Introduction High defibrillation threshold (DFT) is a clinical problem in 1–8% of implantable cardioverter‐defibrillator implants. Some clinicians and…”
Get full text

The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring by Mehlman, Yonatan, Valledor, Andrea Fernendez, Moeller, Cathrine, Rubinstein, Gal, Lotan, Dor, Rahman, Salwa, Oh, Kyung T., Bae, David, DeFilippis, Ersilia M., Lin, Edward F., Lee, Sun Hi, Raikhelkar, Jayant K., Fried, Justin, Theodoropoulos, Kleanthis, Colombo, Paolo C., Yuzefpolskaya, Melana, Latif, Farhana, Clerkin, Kevin J., Sayer, Gabriel T., Uriel, Nir

“…Introduction Monitoring for graft rejection is a fundamental tenet of post‐transplant follow‐up. In heart transplantation (HT) in particular, rejection has…”
Get full text

United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis by Griffin, Jan M., Chiu, Leonard, Axsom, Kelly M., Bijou, Rachel, Clerkin, Kevin J., Colombo, Paolo, Cuomo, Margaret O., De Los Santos, Jeffeny, Fried, Justin A., Goldsmith, Jeff, Habal, Marlena, Haythe, Jennifer, Helmke, Stephen, Horn, Evelyn M., Latif, Farhana, Hi Lee, Sun, Lin, Edward F., Naka, Yoshifumi, Raikhelkar, Jayant, Restaino, Susan, Sayer, Gabriel T., Takayama, Hiroo, Takeda, Koji, Teruya, Sergio, Topkara, Veli, Tsai, Emily J., Uriel, Nir, Yuzefpolskaya, Melana, Farr, Maryjane A., Maurer, Mathew S.

“…Light‐chain (AL) cardiac amyloidosis (CA) has a worse prognosis than transthyretin (ATTR) CA. In this single‐center study, we compared post‐heart transplant…”
Get full text

IDENTIFYING SUBGROUPS OF PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION MORE LIKELY TO BENEFIT FROM A CENTRALIZED HEART FAILURE MANAGEMENT PROGRAM FOR RAPID UP-TITRATION OF GUIDELINE-DIRECTED MEDICAL THERAPY by Harris, Erin, Carey, Matthew R., Lancet, Erica, Alishetti, Shudhanshu, Bhatt, Reema, Lin, Edward F., Oren, Daniel, Iftikhar, Momina, Huang, Sonia, Vasconcellos, Julianne, Webb, Emily, Fisher, Danielle Skinder, Sayer, Gabriel, Uriel, Nir, Axsom, Kelly

Get full text

Impact Of A Remote Centralized Heart Failure Management Program On Guideline-directed Medical Therapy Prescribing To Patients With Heart Failure With Reduced Ejection Fraction At A Multi-hospital Academic Health System by Carey, Matthew R., Lancet, Erica, Alishetti, Shudhanshu, Bhatt, Reema, Lin, Edward F., Oren, Daniel, Iftikhar, Momina, Huang, Sonia, Vasconcellos, Julianne, Webb, Emily, Fisher, Danielle, Sayer, Gabriel T., Uriel, Nir, Axsom, Kelly

“…Despite evidence demonstrating the impact of guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF) on outcomes,…”
Get full text

Outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis by Griffin, Jan M., Chiu, Leonard, Axsom, Kelly M., Bijou, Rachel, Clerkin, Kevin J., Colombo, Paolo, Cuomo, Margaret O., De Los Santos, Jeffeny, Fried, Justin A., Goldsmith, Jeff, Habal, Marlena, Haythe, Jennifer, Helmke, Stephen, Horn, Evelyn M., Latif, Farhana, Hi Lee, Sun, Lin, Edward F., Naka, Yoshifumi, Raikhelkar, Jayant, Restaino, Susan, Sayer, Gabriel T., Takayama, Hiroo, Takeda, Koji, Teruya, Sergio, Topkara, Veli, Tsai, Emily J., Uriel, Nir, Yuzefpolskaya, Melana, Farr, Maryjane A., Maurer, Mathew S.

“…Light‐chain (AL) cardiac amyloidosis (CA) has a worse prognosis than transthyretin (ATTR) CA. In this single‐center study, we compared post‐heart transplant…”
Get full text